|
Volumn 182, Issue 5, 2009, Pages 2203-
|
Editorial Comment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
KI 67 ANTIGEN;
IMMUNOLOGICAL ADJUVANT;
BLADDER CANCER;
CANCER GRADING;
CANCER GROWTH;
CANCER RECURRENCE;
CANCER SURGERY;
CARCINOMA IN SITU;
CYSTECTOMY;
HISTOLOGY;
HUMAN;
NON MUSCLE INVASIVE BLADDER CANCER;
NOTE;
PRIORITY JOURNAL;
BLADDER TUMOR;
CANCER INVASION;
DISEASE COURSE;
PATHOLOGY;
PROGNOSIS;
TUMOR RECURRENCE;
ADJUVANTS, IMMUNOLOGIC;
BCG VACCINE;
DISEASE PROGRESSION;
HUMANS;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
URINARY BLADDER NEOPLASMS;
|
EID: 70350445358
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1016/j.juro.2009.07.148 Document Type: Note |
Times cited : (1)
|
References (0)
|